Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
about
Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in MexicoHerpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's DiseaseChronic hepatitis C virus infection and lipoprotein metabolismHepatitis C Lipo-Viro-Particle from Chronically Infected Patients Interferes with TLR4 Signaling in Dendritic CellDo high lipids help clearance of hepatitis C?Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteinsHuman Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell CultureApolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature reviewApolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progressionAntibody levels to persistent pathogens and incident stroke in Mexican AmericansGenes and hepatitis C: susceptibility, fibrosis progression and response to treatment.Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural FeaturesHuman plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphismThe C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus.Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.Cross-talk between apolipoprotein E and cytokinesTheoretical basis of a beneficial role for vitamin D in viral hepatitis.Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.Association of apolipoprotein E with the progression of hepatitis B virus-related liver disease.ApoE4 upregulates the activity of mitochondria-associated ER membranes.Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.Immunologic, metabolic and genetic factors in hepatitis C virus infection.Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches.ApoE genotype: from geographic distribution to function and responsiveness to dietary factors.Lipids and HCV.Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a.Identification of microRNAs involved in dexamethasone-induced muscle atrophy.Apolipoprotein E-ε4 deficiency and cognitive function in hepatitis C virus-infected patients.Cell surface expression of LDL receptor in chronic hepatitis C: correlation with viral load.Investigation of the relationship between apolipoprotein E gene polymorphisms and hepatitis B virus infection in northern China.APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolism.Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease.Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer’s Disease.HCV Receptors and Virus Entry
P2860
Q26778035-B71E0AEC-6952-4CD7-8005-DA7BF9C2400CQ26781578-086E3BDC-9B84-4A17-89C1-D0D1C5BFF174Q26784234-2E4D331A-3EC5-4217-973A-B4527D9C5C3BQ27478174-07DCB744-4B00-418D-B41D-ECF014702AFBQ27481043-4FC30050-9822-4E5F-92B2-A1C1D11F93ECQ27481398-B4C57537-04C1-40E2-8336-8E9F1044FA2DQ27485012-142A68C1-7A64-4E1B-84FC-328FAD43B13CQ27491003-0F01E1DB-9F19-44F9-A7FC-BACA7A4A7F7AQ28284354-A6103266-9B90-4855-8B06-824E068E8B2BQ31120630-11CD8E6A-7D4A-4DA8-982A-B2FF8B763D53Q33350754-E21E44B5-D5F9-4080-B7DA-72B979C4648BQ33813945-57391300-FE46-4A2D-AAD9-048E47154DD9Q33933106-1F4862EF-2273-4979-8B6F-038EE271CCA6Q34190545-598039D4-5EEC-445E-9C6B-2E8E2548729FQ34295937-9DD14300-9FD8-4D0A-90E0-1DBC2B36BEC0Q35104765-DF58B91D-2D46-4E2A-9A6E-6EA421EF7AE7Q36316676-5F433DA1-0D60-4F53-A08B-72254ED40F35Q36387245-137C5E49-B4B1-4158-8C58-22BDC6207CC3Q36464605-FEA96E48-BC80-49C7-9164-E51D5532C959Q36478666-57988953-4E20-4C90-BFBA-C3537C902B4BQ37015738-CC1010D6-810A-465E-A5F4-16743E8C452FQ37362755-FBD748A8-90CD-4930-B335-706291F81781Q37682496-B2978E4A-6F88-4001-B185-5D630984E1B7Q37688134-4A63D246-F952-44A1-934E-6C945F7B0209Q38008109-CD51DD37-DCF0-4EF7-8BE8-DC0BD17B64B8Q38056643-90798185-DB5D-4FF8-8B90-B3E3D2B44AC1Q38768436-5397EB04-B549-42E9-90C8-10476335BD3FQ39146391-48399DFE-ACE3-46FB-8C1A-D8550C5CE251Q40607877-FDAD8E39-2D60-4AAC-A6D1-D9A3B02E759EQ43037514-88E1EBF8-7CF9-4E4B-985D-4AA855313068Q45372220-3EB94566-EE70-4B60-AC11-DE14203F7B32Q47547827-FCBBBEA3-99DF-4AF3-842D-F1A7CFC18878Q51761118-0F4C9C8A-0222-4C17-B7D9-261D12E46892Q55021072-45466CC6-6E39-4645-BBAB-DAA84A35FD1BQ57564402-6605F5AA-CD5B-495D-9DB2-ED0D4837676F
P2860
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@ast
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@en
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@nl
type
label
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@ast
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@en
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@nl
prefLabel
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@ast
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@en
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@nl
P2093
P2860
P356
P1433
P1476
Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection
@en
P2093
C M Morris
M F Bassendine
M L Schmid
P T Donaldson
S M Norris
P2860
P356
10.1136/GUT.2005.079905
P407
P577
2006-05-01T00:00:00Z